Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase
- Name
- Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase
- Accession Number
- DBCAT004007
- Description
Not Available
- Drugs
Drug Drug Description Cerliponase alfa An enzyme replacement therapy used to treat neuronal ceroid lipofuscinosis type 2 (CLN2) disease, also known as tripeptidyl peptidase 1 (TPP1) deficiency. - Drugs & Drug Targets
Drug Target Type Cerliponase alfa Cation-independent mannose-6-phosphate receptor target